Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor-Reference-Cited by-同舟云学术

Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor

Published:2000-03 Issue:5 Volume:74 Page:2451-2454
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Haan Keith M.¹,Kwok William W.²,Longnecker Richard¹,Speck Peter¹

Affiliation:

1. Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611,1 and

2. Virginia Mason Research Center, Seattle, Washington 981012

Abstract

ABSTRACT Epstein-Barr virus (EBV) glycoprotein gp350/gp220 association with cellular CD21 facilitates virion attachment to B lymphocytes. Membrane fusion requires the additional interaction between virion gp42 and cellular HLA-DR. This binding is thought to catalyze membrane fusion through a further association with the gp85-gp25 (gH-gL) complex. Cell lines expressing CD21 but lacking expression of HLA class II molecules are resistant to infection by a recombinant EBV expressing enhanced green fluorescent protein. Surface expression of HLA-DR, HLA-DP, or HLA-DQ confers susceptibility to EBV infection on resistant cells that express CD21. Therefore, HLA-DP or HLA-DQ can substitute for HLA-DR and serve as a coreceptor in EBV entry.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.74.5.2451-2454.2000

Reference35 articles.

1. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor;Ahearn J. M.;Proc. Natl. Acad. Sci. USA,1988

2. CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

3. Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci

4. Regulation of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon;Basham T.;Hum. Immunol.,1984

5. Identification of an interferon-gamma response region 5′ of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines;Basta P. V.;J. Immunol.,1987

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update of Natural Products and Their Derivatives Targeting Epstein–Barr Infection;Viruses;2024-01-15

2. Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients;Life;2024-01-09

3. Molecular Mechanisms of Severe Diseases Caused by Epstein-Barr Virus Infection;Current Clinical Microbiology Reports;2023-09-13

4. Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation;Biomedicine & Pharmacotherapy;2023-08

5. Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy;Journal of Medical Virology;2023-05